What is ductal carcinoma in situ? Being told you have ductal carcinoma in situ can be confusing. It has the word carcinoma in its name, yet doctors may also tell you it is not invasive cancer and may call it Stage 0. Both things are true, and this guide explains how they fit together.
Ductal carcinoma in situ, often shortened to DCIS, means that abnormal cells are sitting inside the milk ducts of the breast and have not spread into the tissue around them. It is the earliest form of breast cancer, and many people feel a mix of relief and worry when they hear the diagnosis.
The sections below explain what DCIS is in plain words, how it is found, how it is graded, and which treatment choices are usually discussed.
What Is Ductal Carcinoma in Situ in Plain Words
The words in situ come from Latin and simply mean in its original place. For DCIS, that place is inside the milk duct. The cells have changed and are growing in a way they should not, but they are still contained where they started.
This matters because cells that stay inside the duct cannot travel to the lymph nodes or to other parts of the body. Without the ability to spread, DCIS itself is not life threatening. Doctors still take it seriously, because in some people DCIS can, over time, develop into invasive breast cancer if it is left untreated.
Where DCIS Starts and Why It Is Stage 0
The breast is made of lobules, which produce milk, and ducts, which carry milk to the nipple. DCIS starts when cells lining one of the ducts begin to change. Viewed under a microscope, the duct may be filled with abnormal cells, yet its wall remains unbroken.
Doctors group cancers into stages based on how far they have spread. Because DCIS has not invaded nearby tissue and cannot have reached the lymph nodes, it sits at the very beginning of the scale, which is why it is called Stage 0. Invasive cancers, by contrast, start at Stage 1.
How DCIS Is Usually Found
Most DCIS causes no lump and no symptoms at all, so it is usually found during routine screening. On a mammogram it often appears as tiny specks of calcium in the ducts, called calcifications. These specks can have many causes, and most are harmless, but certain patterns lead the radiologist to suggest a closer look.
If screening shows an area of concern, the usual next step is a diagnostic mammogram with extra views, and then a biopsy if the area still looks suspicious. A core needle biopsy removes small samples of tissue, and a pathologist confirms whether DCIS is present. Less often, DCIS is found because of nipple discharge, a lump, or changes in the nipple itself. Those symptoms always deserve a prompt check.
Grades and Hormone Receptor Tests for DCIS
The pathology report describes DCIS by grade, which reflects how abnormal the cells look and how fast they may be growing. Low grade DCIS tends to grow slowly. High grade DCIS has cells that look quite different from normal cells and may progress sooner.
Another feature in the report is necrosis, areas where cells in the middle of the duct have died because they grew quickly. Doctors also test DCIS for hormone receptors. Many DCIS cases are estrogen receptor positive, which means estrogen helps the cells grow. That result matters because hormone therapy may be offered to lower the chance of DCIS or invasive cancer coming back in either breast.
Treatment Choices Doctors Usually Discuss
Treatment for DCIS aims to remove the abnormal cells and lower the chance of invasive cancer developing later. The most common path is surgery. Many people have a lumpectomy, which removes the area of DCIS with a border of normal tissue around it, and keep the rest of the breast.
Radiation after a lumpectomy is often discussed, because it lowers the chance of DCIS returning in the same breast. Some people with a small area of low grade DCIS may talk with their team about whether radiation can safely be left out. A mastectomy, which removes the whole breast, may be suggested when DCIS is spread through a large area or appears in several places.
Hormone therapy in tablet form may be offered when DCIS is estrogen receptor positive, mainly to lower the risk of a new problem in either breast. Chemotherapy is not used for DCIS, because the cells cannot spread beyond the duct.
Monitoring, Risk and Questions to Ask
After treatment, monitoring usually includes regular mammograms and breast exams, so any change is spotted early. Most people treated for DCIS do very well. There is still a small chance of DCIS coming back or of invasive cancer developing later in the same breast or the other breast, which is why follow up care matters.
It is natural to have questions, and writing them down before appointments helps. People often ask about the grade of their DCIS and its hormone receptor result, how large the area is, whether radiation is likely, and how often mammograms will be needed afterward.
Frequently Asked Questions
Is DCIS really cancer if it cannot spread?
DCIS is described as the earliest form of breast cancer because the cells look like cancer cells under the microscope, yet they stay inside the duct and cannot spread. It is not an emergency, but it is not nothing either, which is why doctors discuss treatment rather than simply ignoring it.
Can DCIS turn into invasive cancer?
It can, in some cases, over months or years, but not every case would progress if left alone. At present, doctors cannot reliably tell which cases would stay quiet and which would become invasive, so treatment or careful monitoring is usually discussed for everyone.
If I have a mastectomy for DCIS, will I still need follow up?
Yes, though the risk in that breast becomes very low. Your team will still arrange regular checks of the other breast and routine mammograms for it. Report any new change in the chest area promptly.
A Note on Medical Information
The information on this website is for general educational purposes only and is not medical advice. It does not replace the advice, diagnosis, or treatment of a qualified healthcare professional. If you notice a change in your breast or have concerns about your health, please contact a healthcare professional promptly.